|
|
|
 |
FDA Approval Activities for this Drug…
Trileptal (oxcarbazepine) Tablets, Novartis Pharmaceutical NDA 21-014/S-003 8/7/03 8/15/03 | Trileptal (oxcarbazepine) Tablets and Suspension, Novartis Pharmaceutical NDA 21-014/S-007 & 21-285/S-004 Trileptal (Oxcarbazepine) Tablets & Suspension, Novartis NDA 21-014/S6 & 21-285/S2 4/1/02 4/8/02 | Trileptal (oxcarbazepine) Tablets, Novartis NDA 21-014/S3 8/7/03 8/15/03 Trileptal (oxcarbazepine) Tablets, Novartis NDA 21-014 1/10/99 1/19/00 1/19/00 2/28/02 | Trileptal (oxcarbazepine) Tablets and Suspension, Novartis NDA 21-014/S-007 & 21-285/S-004 | Triletpal (oxcarbazepine) Tablets, Novartis Pharma, Labeling Revision | Triletpal (oxcarbazepine) Oral Solution, Novartis Pharma, Labeling Revision | Trileptal (oxcarbazepine) tablets, Novartis Pharma, Control Supplement | Trileptal (oxcarbazepine) Tablets, Novartis, Labeling Revision | Trileptal (oxcarbazapine) Oral Solution, Novartis Pharma, Labeling Revision | Trileptal (oxcarbazapine) Tablets, Novartis Pharma, Labeling Revision | Oxcarbazepine Tablets, Glenmark Pharma, Approval | Oxcarbazepine Tablets, Sun Pharma, Approval | Oxcarbazepine Tablets, Roxane Labs, Approval | Oxcarbazepine Tablets, Apotex, Tentative Approval | Oxcarbazepine Tablets, Taro Pharma, Approval | Oxcarbazepine Tablets, Teva Pharma, Approval | Oxcarbazepine, Tablets, Breckenridge Pharmaceutical, Inc., Approval | Oxcarbazepine Tablets, Breckenridge Pharma, Approval | Oxcarbazepine Tablets, Apotex, Approval | Trileptal (oxcarbazepine) Oral Suspension, Novartis Pharmaceuticals Corp., Labeling Revision | Trileptal (oxcarbazepine) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Oxcarbazepine Oral Suspension, Ranbaxy Laboratories Ltd., Approval | Oxcarbazepine Tablets, Cadista Pharmaceuticals, Inc., Approval | Trileptal (oxcarbazepine) Oral Suspension, Novartis Pharmaceuticals Corp., Labeling Revision | Trileptal (oxcarbazepine) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision
  
|